The novel –G646A polymorphism of the TNFα promoter is associated with the HLA‐B51 allele in Korean patients with Behçet's disease

References

• Sakane T., Takeno M., Suzuki N., Inaba G. Behçet's disease. N Engl J Med 1999; 341: 1284–91
   PubMed Web of Science ®Google Scholar
• International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078–80
   PubMed Web of Science ®Google Scholar
• Takeno M., Kariyone A., Yamashita N., Takiguchi M., Mizushima Y., Kaneoka H., et al. Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA‐B51 transgenic mice. Arthritis Rheum 1995; 38: 426–33
   PubMed Web of Science ®Google Scholar
• Mege J. L., Dilsen N., Sanguedolce V., Gul A., Bongrand P., Roux H., et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL)‐6, IL‐8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993; 20: 1544–9
   PubMed Web of Science ®Google Scholar
• Direskeneli H. Behçet's disease: infectious aetiology, new autoantigens, and HLA‐B51. Ann Rheum Dis 2001; 60: 996–1002
   PubMed Web of Science ®Google Scholar
• Arayssi T., Hamdan A. New insights into the pathogenesis and therapy of Behçet's disease. Curr Opin Pharmacol 2004; 4: 183–8
   PubMed Web of Science ®Google Scholar
• Ohno S., Ohguchi M., Hirose S., Matsuda H., Wakisaka A., Aizawa M. Close association of HLA‐Bw51 with Behçet's disease. Arch Ophthalmol 1982; 100: 1455–8
   PubMed Web of Science ®Google Scholar
• Kera J., Mizuki N., Ota M., Katsuyama Y., Pivetti‐Pezzi P., Ohno S., et al. Significant associations of HLA‐B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients. Tissue Antigens 1999; 54: 565–71
   PubMed Web of Science ®Google Scholar
• Ahmad T., Wallace G. R., James T., Neville M., Bunce M., Mulcahy‐Hawes K., et al. Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms?. Arthritis Rheum 2003; 48: 807–13
   PubMed Web of Science ®Google Scholar
• Mizuki N., Ohno S., Sato T., Ishihara M., Miyata S., Nakamura S., et al. Microsatellite polymorphism between the tumor necrosis factor and HLA‐B genes in Behçet's disease. Hum Immunol 1995; 43: 129–35
   PubMed Web of Science ®Google Scholar
• Gul A. Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19((Suppl 24))S6–12
   Google Scholar
• Sayinalp N., Ozcebe O. I., Ozdemir O., Haznedaroglu I. C., Dundar S., Kirazli S. Cytokines in Behçet's disease. J Rheumatol 1996; 23: 321–2
   PubMed Web of Science ®Google Scholar
• Hasan A., Fortune F., Wilson A., Warr K., Shinnick T., Mizushima Y., et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996; 347: 789–94
   PubMed Web of Science ®Google Scholar
• Goossens P. H., Verburg R. J., Breedveld F. C. Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis 2001; 60: 637
   PubMed Web of Science ®Google Scholar
• Wilson A. G., de Vries N., Pociot F., di Giovine F. S., van der Putte L. B., Duff G. W. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. Exp Med 1993; 177: 557–60
   PubMed Web of Science ®Google Scholar
• McGuire W., Hill A. V., Allsopp C. E., Greenwood B. M., Kwiatkowski D. Variation in the TNF‐alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508–10
   PubMed Web of Science ®Google Scholar
• Field M. Tumour necrosis factor polymorphisms in rheumatic diseases. Q J Med 2001; 94: 237–46
   Google Scholar
• Verity D. H., Wallace G. R., Vaughan R. W., Kondeatis E., Madanat W., Zureikat H., et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens 1999; 54: 264–72
   PubMed Web of Science ®Google Scholar
• Duymaz‐Tozkir J., Gul A., Uyar F. A., Ozbek U., Saruhan‐Direskeneli G. Tumour necrosis factor‐alpha gene promoter region –308 and –376 G→A polymorphisms in Behçet's disease. Clin Exp Rheumatol 2003; 21((Suppl 30))S15–18
   Google Scholar
• Ates A., Kinikli G., Duzgun N., Duman M. Lack of association of tumor necrosis factor–alpha gene polymorphisms with disease susceptibility and severity in Behçet's disease. Rheumatol Int 2006; 26: 348–53
   PubMed Web of Science ®Google Scholar
• Lee E. B., Kim J. Y., Lee Y. J., Park M. H., Song Y. W. TNF and TNF receptor polymorphisms in Korean Behçet's disease patients. Hum Immunol 2003; 64: 614–20
   PubMed Web of Science ®Google Scholar
• Chang H. K., Cheon K. S. The clinical significance of a pathergy reaction in patients with Behçet's disease. J Korean Med Sci 2002; 17: 371–4
   PubMedGoogle Scholar
• Walsh P. S., Metzger D. A., Higuchi R. Chelex® 100 as a medium for simple extraction of DNA for PCR–based typing from forensic material. BioTechniques 1991; 10: 506–13
   PubMed Web of Science ®Google Scholar
• Chang H. K., Kim J. U., Cheon K. S., Chung H. R., Lee K. W., Lee I. H. HLA‐B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea. Clin Exp Rheumatol 2001; 19((Suppl 24))S31–5
   Google Scholar
• Jung H. Y., Park J. S., Park Y. J., Kim Y. J., Kimm K., Koh I. S. HapAnalyzer: minimum haplotype analysis system for association studies. Genomics Inform 2004; 2: 107–9
   Google Scholar